Sirolimus-Eluting Stent Implantation for Ostial Left Anterior Descending Coronary Artery Lesions

Author:

Kishi Koichi1,Kimura Takeshi1,Morimoto Takeshi1,Namura Masanobu1,Muramatsu Toshiya1,Nishikawa Hideo1,Hiasa Yoshikazu1,Isshiki Takaaki1,Nobuyoshi Masakiyo1,Mitsudo Kazuaki1,

Affiliation:

1. From the Division of Cardiology, Tokushima Red Cross Hospital, Tokushima, Japan (K.K., Y.H.); Department of Cardiovascular Medicine (T.K.) and Center for Medical Education and Clinical Epidemiology Unit (T. Morimoto), Graduate School of Medicine, Kyoto University, Kyoto, Japan; Division of Cardiology, Kanazawa Cardiovascular Hospital, Kanazawa, Japan (M. Namura); Division of Cardiology, Kawasaki Social Insurance Hospital, Kanagawa, Japan (T. Muramatsu); Division of Cardiology, Mie Heart Center, Mie,...

Abstract

Background— Ostial left anterior descending coronary artery (LAD) lesion has been regarded as a lesion subset unsuitable for coronary stenting. Long-term outcomes of sirolimus-eluting stent (SES) implantation for ostial LAD lesions have not been adequately evaluated. Methods and Results— Among 12 824 patients enrolled in the j-Cypher Registry, 3-year outcomes were compared between 481 patients with SES-treated ostial LAD lesions and 5369 patients with SES-treated nonostial proximal LAD lesions. Patients with ostial LAD lesions had similar incidences of target lesion revascularization (TLR) as those with nonostial proximal LAD lesions (9.4% versus 9.7%; P =0.98; adjusted hazard ratio [HR], 0.99; 95% CI, 0.7 to 1.36; P =0.94) and death/myocardial infarction (MI) (10.7% versus 11.4%; P =0.82; adjusted HR, 1.05; 95% CI, 0.76 to 1.4; P =0.77). Among the patients with ostial LAD lesions, those undergoing both main and side branch stenting (n=62) compared to main branch stenting alone (n=419) had a higher risk for TLR (adjusted HR, 4.65; 95% CI, 2.32 to 9.25; P <0.0001) but similar risk for death/MI (adjusted HR, 1.15; 95% CI, 0.49 to 2.41; P =0.73). In patients with main branch stenting alone, outcomes after crossover stenting across the circumflex coronary artery (n=225) were not different from those after ostial stenting (n=194) for TLR (adjusted HR, 0.77; 95% CI, 0.33 to 1.82; P =0.55) and for death/MI (adjusted HR, 1.54; 95% CI, 0.78 to 3.2; P =0.22). Conclusions— In terms of both safety and efficacy, 3-year outcomes of percutaneous coronary intervention using SES for ostial LAD lesions were comparable to those for nonostial proximal LAD lesions. Crossover stenting with a 1-stent approach might be a reasonable option in treating ostial LAD lesions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3